Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
72 /100
HIGH RISK
Score updated Aug 28, 2026

IGC — IGC Pharma, Inc. Dilution Risk Tracker

Track IGC dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track IGC — Get alerts when the score changes →

As of August 28, 2026, IGC Pharma, Inc. (IGC) has a DilutionWatch DilutionScore of 72/100, rated HIGH dilution risk. IGC Pharma, Inc. has a market capitalization of $28.92M, 103.38M shares outstanding.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
66
💰 Cash Runway
95
📊 Float Risk
2
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

⛈️
Warning
High probability of dilution event
model est. 53%
🔄 Reverse Split model est. 70%
• 50-day avg $0.30 below $1 exchange minimum
• Only 1 months cash — financial pressure
💰 Capital Raise model 55%
• Critical: only 0.8 months cash remaining
📉 Score Deterioration model 10%
• Score in HIGH risk zone (72/100)
🔔 Track IGC — Get forecast alerts →

Market Data

Market Cap$28.92M
Shares Outstanding103.38M
Float90.22M
Cash$354.0K
Debt$136.0K
Short InterestN/A

Institutional Holdings

21.7% institutional ownership
Source: Yahoo Finance · Detailed 13F holder data available for tracked tickers
🔔 Track IGC for full holder detail →

Short Interest

Short Interest541.7K
Days to Cover1.7
% of Float0.6%
FINRA data as of Jul 31, 2026

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2019-03-31
8-K 8K EVENT 2026-04-20
4 INSIDER TRANSACTION 2026-04-06
4 INSIDER TRANSACTION 2026-04-06
4 INSIDER TRANSACTION 2026-04-06
Full SEC filing analysis available with free account

Recent News

No recent news

Factual IGC Dilution Snapshot

IGC Pharma, Inc. (IGC) has a DilutionScore of 72/100, rated High dilution risk. Score date: August 28, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track IGC Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking IGC — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for IGC
IGC FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.